Medium Tactile Pressure for Lymphedema

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
University of Colorado Anschutz Medical Campus, Aurora, CO
Lymphedema+1 More
Pressure - Procedure
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The purpose of this study is to establish optimal guidelines for Manual Lymphatic Drainage in participants with lower extremity lymphedema.

Eligible Conditions

  • Lymphedema

Treatment Effectiveness

Study Objectives

1 Primary · 8 Secondary · Reporting Duration: 18 months

18 Months
Change in Basal Metabolic Rate (BMR) in lbs
Change in Fat Mass in lbs
Change in Free Fat Mass in lbs
Change in Intracellular Fluid in liters
Change in Skeletal Muscle Mass in lbs
Change in Total body weight in liters
18 months
Change in Basal Metabolic Rate in kg/m^2
Change in Extracellular Fluid in liters
Change in The L-dex (Lymphedema Index).

Trial Safety

Trial Design

3 Treatment Groups

Medium Tactile Pressure
1 of 3
Light Tactile Pressure
1 of 3
Firm Tactile Pressure
1 of 3
Active Control

72 Total Participants · 3 Treatment Groups

Primary Treatment: Medium Tactile Pressure · No Placebo Group · N/A

Medium Tactile Pressure
Procedure
ActiveComparator Group · 1 Intervention: Pressure · Intervention Types: Procedure
Light Tactile Pressure
Procedure
ActiveComparator Group · 1 Intervention: Pressure · Intervention Types: Procedure
Firm Tactile Pressure
Procedure
ActiveComparator Group · 1 Intervention: Pressure · Intervention Types: Procedure

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 18 months
Closest Location: University of Colorado Anschutz Medical Campus · Aurora, CO
Photo of aurora 1Photo of aurora 2Photo of aurora 3
2015First Recorded Clinical Trial
1 TrialsResearching Lymphedema
91 CompletedClinical Trials

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,554 Previous Clinical Trials
1,910,456 Total Patients Enrolled
Marco Del ChiaroPrincipal InvestigatorUniversity of Colorado Denver | Anschutz

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are between the age of 30 and 75 years.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.